Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparison - 05/12/20
Authors Dee and Fefer contributed equally to this work. |
|
Funding sources: Dr Nguyen receives National Institutes of Health funding through National Cancer Institute grant R01-CA-240582. |
|
Conflicts of interest: Dr Mahal receives funding from the Prostate Cancer Foundation and the American Society for Radiation Oncology. Dr Nguyen receives support from Bayer, Astellas, Ferring, Dendreon, Blue Earth, Genome Dx, Augmenix, Boston Scientific, Janssen, and Cota Healthcare. |
|
IRB approval status: The Dana-Farber Cancer Institute Institutional Review Board approved this study protocol (DFCI 18-416). |
|
Reprints not available from the authors. |
Vol 84 - N° 1
P. 168-172 - janvier 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?